These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 9860506)

  • 1. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of trans-4,5-dihydroxy-4,5-dihydrobenzo[a]pyrene to benzo[a]pyrene bis-diols and DNA adducts by induced rat liver microsomes.
    Padgett WT; Davis C; Lambert G; Nelson GB; Ross JA; Yacopucci M; Nesnow S
    Chem Res Toxicol; 2000 Nov; 13(11):1125-34. PubMed ID: 11087434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
    King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
    Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
    Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
    Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
    Luch A; Platt KL; Seidel A
    Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,l]pyrene and Dibenzo[a,l]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro.
    Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1999 Sep; 12(9):796-801. PubMed ID: 10490500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proximate carcinogen trans-3,4-dihydroxy-3,4-dihydro-dibenz[c,h]acridine is oxidized stereoselectively and regioselectively by cytochrome 1A1, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats.
    Adams JD; Sayer JM; Chadha A; Shirai N; Lehr RE; Kumar S; Jerina DM
    Chem Biol Interact; 1999 Sep; 122(2):117-35. PubMed ID: 10528997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
    Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
    Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures.
    Ralston SL; Lau HH; Seidel A; Luch A; Platt KL; Baird WM
    Cancer Res; 1994 Feb; 54(4):887-90. PubMed ID: 8313376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies.
    Jankowiak R; Ariese F; Hewer A; Luch A; Zamzow D; Hughes NC; Phillips D; Seidel A; Platt KL; Oesch F; Small GJ
    Chem Res Toxicol; 1998 Jun; 11(6):674-85. PubMed ID: 9625736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
    Amin S; Desai D; Dai W; Harvey RG; Hecht SS
    Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative metabolism of the aza polynuclear aromatic hydrocarbon dibenz[a,h]acridine by recombinant human and rat cytochrome P450s.
    Yuan ZX; Kumar S; Sikka HC
    Chem Res Toxicol; 2004 May; 17(5):672-8. PubMed ID: 15144224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational studies of stereoisomeric tetrols derived from syn- and anti-dibenzo[a,l]pyrene diol epoxides.
    Jankowiak R; Ariese F; Zamzow D; Luch A; Kroth H; Seidel A; Small GJ
    Chem Res Toxicol; 1997 Jun; 10(6):677-86. PubMed ID: 9208175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8,9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell-transforming agent in C3H10T(1)/(2)Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts.
    Nesnow S; Davis C; Padgett WT; Adams L; Yacopucci M; King LC
    Carcinogenesis; 2000 Jun; 21(6):1253-7. PubMed ID: 10837018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective metabolism of the (+)-(S,S)- and (-)-(R,R)-enantiomers of trans-3,4-dihydroxy-3,4-dihydrobenzo[c]-phenanthrene by rat and mouse liver microsomes and by a purified and reconstituted cytochrome P-450 system.
    Thakker DR; Levin W; Yagi H; Yeh HJ; Ryan DE; Thomas PE; Conney AH; Jerina DM
    J Biol Chem; 1986 Apr; 261(12):5404-13. PubMed ID: 3957930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.